One of the most feared outcomes in children and adolescents with ADHD is the development of alcohol or drug abuse or dependence, referred to here as substance use disorders (SUD).
Neurodevelopmental disorders from in utero COVID-19 exposure based on sex
In a recent study, female offspring of mothers with a positive COVID-19 test during pregnancy were at a decreased risk of developing neurodevelopmental disorders compared to male offspring.
ADHD Medications: A Look at Their Safety Profile
Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.
The impact of mild sleep deprivation on the quality of life in children
As little as 39 minutes less sleep per night for 1 week can have an impact on the quality of life of children.
Early initiation, quick escalation to high-intensity drinking can promote screening in adolescents
According to a recently published study, identification of early initiation and quick escalation to high-intensity drinking in adolescents and young adults can increase screenings for these types of behaviors.
Managing aggression in pediatric patients
At the 44th National Association of Pediatric Nurse Practitioners Conference, pediatric aggression was discussed, including which patients are at greater risk and which management strategies are most appropriate.
SDX/d-MPH safe and effective against pediatric ADHD
In a recent study, positive safety and efficacy outcomes for serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH; Azstarys; KemPharm) were found in children aged 6 years and older with attention-deficit/hyperactivity disorder (ADHD).
2 Clarke Drive Cranbury, NJ 08512